Federal contract award
FA468622F0050
COMMODITY: HEMATOLOGY ANALYZER LEASE TO INCLUDE SERVICING AND REAGENTS FOR THE 9TH MEDICAL GROUP LABORATORY
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | FA4686 9 CONS PK |
| NAICS | 334516 — Analytical Laboratory Instrument Manufacturing |
| PSC | 6640 — Laboratory Equipment and Supplies |
| Parent award / vehicle | V797D40235 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $114.3K |
| Current contract value | $114.3K |
| Potential contract value / ceiling | $152.4K |
| Start date | Sep 26, 2022 |
| Current end date | Sep 26, 2025 |
| Potential end date | Sep 26, 2025 |
| Latest award activity | Sep 9, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 9, 2025 | P00006 | $-38.1K | SERVICE: THE SPECIFICATIONS OF THE SYSTEM MUST BE ABLE TO PERFORM PATIENT TESTING USING WHOLE BLOOD TO PERFORM THE FOLLOWING FULLY AUTOMATED TESTS OFFERED ON CURRENT TEST MENU: WBC, RBC, HCT, HGB, MCV, MCH, MCHC, PLT, RDW-CV, MPV, NEUT ABSOLUTE |
| Jul 21, 2025 | P00005 | $38.1K | COMMODITY: SPECIFICATIONS OF SYSTEM MUST BE ABLE TO PERFORM PATIENT TESTING USING WHOLE BLOOD TO PERFORM THE FOLLOWING FULLY AUTOMATED TESTS ON CURRENT TEST MENU: WBC, RBC, HCT, HGB, MCV, MCH, MCHC, PLT, RDW-CV, MPV, NEUT ABSOLUTE (#), PERCENT ( |
| Apr 9, 2025 | P00004 | $0 | SERVICE: THE SPECIFICATIONS OF SYSTEM MUST BE ABLE TO PERFORM PATIENT TESTING USING WHOLE BLOOD TO PERFORM THE FOLLOWING FULLY AUTOMATED TESTS OFFERED ON CURRENT TEST MENU: WBC, RBC, HCT, HGB, MCV, MCH, MCHC, PLT, RDW-CV, MPV, NEUT ABSOLUTE (#), %, |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.